Sicagen India

Which are the latest news on Sicagen India?

Why is Sicagen India Ltd falling/rising?

As of 05-Sep, Sicagen India Ltd's stock price is falling by 1.3% after a trend reversal, underperforming its sector by 2.72%. Despite recent gains over the past week and month, the stock has a year-to-date decline of 5.02% and a significant drop of 24.21% over the past year.

As of 05-Sep, Sicagen India Ltd's stock price is currently falling, with a change of -0.76, representing a decrease of 1.3%. This decline follows a trend reversal after three consecutive days of gains. Additionally, the stock has underperformed its sector by 2.72% today. <BR><BR>Despite a strong performance over the past week and month, where the stock has increased by 6.45% and 15.48% respectively, it has shown a year-to-date decline of 5.02% and a significant drop of 24.21% over the past year. The stock's current price is higher than its 5-day, 50-day, 100-day, and 200-day moving averages, but it is lower than the 20-day moving average, indicating some short-term weakness.<BR><BR>Moreover, while there has been a rise in investor participation, as evidenced by a 7.31% increase in delivery volume compared to the 5-day average, the overall liquidity remains adequate for trading. The combination of these factors contributes to the current decline in the stock price of Sicagen India Ltd.

Who are in the management team of Sicagen India?

The management team of Sicagen India includes B Narendran, Ashwin C Muthiah (Chairman), Sashikala Srikanth, Rita Chandrasekar, S Radhakrishnan, R Chandrasekar, M Rajamani, S R Ramakrishnan, Varma Nandakumar, and Ankita Jain (Company Secretary). This diverse team provides governance and strategic direction for the company.

The management team of Sicagen India includes the following members:<BR><BR>1. **B Narendran** - Independent Director<BR>2. **Ashwin C Muthiah** - Chairman (Non-Executive)<BR>3. **Sashikala Srikanth** - Independent Director<BR>4. **Rita Chandrasekar** - Independent Director<BR>5. **S Radhakrishnan** - Independent Director<BR>6. **R Chandrasekar** - Director<BR>7. **M Rajamani** - Independent Director<BR>8. **S R Ramakrishnan** - Director<BR>9. **Varma Nandakumar** - Additional Director<BR>10. **Ankita Jain** - Company Secretary & Compliance Officer<BR><BR>This team brings a diverse range of expertise to the company, contributing to its governance and strategic direction.

What does Sicagen India do?

Sicagen India Ltd is a Micro Cap company that provides trading and marketing services for construction-related infrastructure. As of June 2026, it reported net sales of 286 Cr and a net profit of 7 Cr.

Overview: <BR>Sicagen India Ltd is a leading provider of trading and marketing services for construction-related industrial and retail infrastructure, operating within the Trading & Distributors industry and classified as a Micro Cap company.<BR><BR>History: <BR>Sicagen India Ltd was incorporated on June 11, 2004. The latest quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 286 Cr (Quarterly Results - Jun 2026) <BR>Most recent Net Profit: 7 Cr (Quarterly Results - Jun 2026) <BR>Market-cap value: INR 214 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 10.00 <BR>Industry P/E: 21 <BR>Dividend Yield: 1.83% <BR>Debt-Equity: 0.15 <BR>Return on Equity: 3.70% <BR>Price to Book: 0.44 <BR><BR>Contact Details: <BR>Address: 4th Floor SPIC House, No 88 Mount Road Guindy Chennai Tamil Nadu : 600032 <BR>Tel: 91-044-4075 4075 <BR>Email: secl@sicagen.com <BR>Website: http://www.sicagen.com

Who are the peers of the Sicagen India?

Sicagen India's peers include Polo Queen Industries, Sakuma Exports, Vikas Lifecare, Chemkart India, Northern Spirits, Signet Industries, Maximus International, Parshva Enterprises, and Dhoot Industrial Finance. Sicagen India has average management risk and a 1-year return of -25.68%, higher than Polo Queen Industries but lower than most peers.

Peers: The peers of Sicagen India are Polo Queen Ind., Sakuma Exports, Vikas Lifecare, Chemkart India, Northern Spirits, Signet Industrie, Maximus Interna., Parshva Enterpr., and Dhoot Indl.Fin.<BR><BR>Quality Snapshot: Excellent management risk is observed at Chemkart India, while Average management risk is found at Sakuma Exports, Northern Spirits, Signet Industrie, Maximus Interna., Dhoot Indl.Fin, and Sicagen India. Below Average management risk is noted for Polo Queen Ind., Vikas Lifecare, and Parshva Enterpr. Growth is Excellent at Northern Spirits, Average at Sicagen India, Sakuma Exports, Maximus Interna., and Dhoot Indl.Fin, and Below Average at Polo Queen Ind., Vikas Lifecare, Chemkart India, Signet Industrie, Parshva Enterpr. and the rest. Capital Structure is Excellent at Chemkart India, Good at Sakuma Exports and Parshva Enterpr., Average at Maximus Interna. and Sicagen India, and Below Average at Polo Queen Ind., Vikas Lifecare, Northern Spirits, Signet Industrie, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Vega Jewellers at 60.24%, while Polo Queen Ind. has the lowest at -80.08%. Sicagen India’s 1-year return is -25.68%, which is higher than Polo Queen Ind. but lower than most peers. Additionally, peers with a negative six-month return include Polo Queen Ind., Sakuma Exports, Vikas Lifecare, and Northern Spirits.

How big is Sicagen India?

As of 31st August, Sicagen India Ltd has a market capitalization of 214.00 Cr, with recent net sales of 1054.90 Cr and a net profit of 20.46 Cr. The company reported shareholder's funds of 495.01 Cr and total assets of 739.53 Cr for the annual period ending March 2026.

As of 31st August, Sicagen India Ltd has a market capitalization of 214.00 Cr, classified as a Micro Cap.<BR><BR>In the latest 4 quarters, Sicagen India reported Net Sales of 1054.90 Cr and a Net Profit of 20.46 Cr.<BR><BR>For the latest annual period ending in March 2026, the company had Shareholder's Funds of 495.01 Cr and Total Assets amounting to 739.53 Cr.

Should I buy, sell or hold Sicagen India Ltd?

When is the next results date for Sicagen India Ltd?

The next results date for Sicagen India Ltd is 10 August 2026.

The next results date for Sicagen India Ltd is scheduled for 10 August 2026.

Are Sicagen India Ltd latest results good or bad?

Sicagen India Ltd's latest results show strong revenue growth with a record ₹277.91 crores in Q4 FY26, but net profit declined 9.53% quarter-on-quarter due to rising interest expenses, raising concerns about profitability sustainability. Investors should be cautious given these mixed signals.

Sicagen India Ltd's latest results present a mixed picture. On one hand, the company achieved its highest-ever quarterly revenue of ₹277.91 crores in Q4 FY26, reflecting a solid year-on-year growth of 10.49% and a sequential increase of 5.16%. This demonstrates healthy demand across its diversified business segments.<BR><BR>However, the net profit for the same quarter was ₹4.46 crores, which is a decline of 9.53% compared to the previous quarter, although it shows a positive year-on-year increase of 12.34%. This sequential profit drop raises concerns about the sustainability of profitability, especially given that interest expenses surged by 60% quarter-on-quarter, significantly impacting the company's margins.<BR><BR>The operating margin stood at 4.04%, which, while improving from the previous quarter, still reflects a slight year-on-year decline. The PAT margin also contracted to 1.60%, indicating pressure on profitability.<BR><BR>Overall, while the revenue growth is a positive sign, the declining net profit and rising interest costs suggest that the company faces significant operational challenges. Investors should be cautious and consider these factors when evaluating the overall performance of Sicagen India Ltd.

How has been the historical performance of Sicagen India?

Sicagen India's historical performance shows fluctuating net sales and profits, peaking at 895.30 Cr in March 2023 before declining slightly to 891.88 Cr in March 2025. Despite this, operating profit and profit before tax improved, indicating enhanced operational efficiency and a stable financial position.

Answer:<BR>The historical performance of Sicagen India shows a fluctuating trend in net sales and profits over the years, with a notable increase in recent periods.<BR><BR>Breakdown:<BR>Sicagen India's net sales peaked at 895.30 Cr in March 2023 but saw a slight decline to 891.88 Cr in March 2025. The total operating income followed a similar pattern, reaching 895.30 Cr in March 2023 and then decreasing to 891.88 Cr in March 2025. The company's total expenditure, excluding depreciation, was 856.38 Cr in March 2025, up from 768.29 Cr in March 2024. Operating profit (PBDIT) increased to 43.56 Cr in March 2025 from 34.26 Cr in March 2024, indicating improved operational efficiency. Profit before tax also rose to 24.18 Cr in March 2025, compared to 13.84 Cr in March 2024, while profit after tax was 17.11 Cr in March 2025, slightly down from 17.82 Cr in March 2023. The company's total assets were 721.69 Cr in March 2025, with total liabilities at 721.69 Cr, reflecting a stable financial position. Cash flow from operating activities improved to 33.00 Cr in March 2025, up from 24.00 Cr in March 2024, contributing to a net cash inflow of 1.00 Cr in March 2025. Overall, Sicagen India has shown resilience with a gradual recovery in profits and cash flow despite fluctuations in sales.

Is Sicagen India overvalued or undervalued?

As of October 24, 2024, Sicagen India is considered very attractive with a PE ratio of 17.29, a Price to Book Value of 0.55, and an EV to EBITDA of 9.79, significantly outperforming its peers and the Sensex, indicating it is undervalued in the market.

As of 24 October 2024, Sicagen India has moved from an attractive to a very attractive valuation grade. The company is currently undervalued, with a PE ratio of 17.29, a Price to Book Value of 0.55, and an EV to EBITDA of 9.79. In comparison to its peers, Sicagen's PEG ratio stands at a notably low 0.37, while MMTC, a peer, has a significantly high PE ratio of 119.39, indicating that Sicagen is positioned favorably within its industry.<BR><BR>The company's recent performance has also been noteworthy, with a one-month stock return of 24.97%, significantly outperforming the Sensex's 3.88% return over the same period. This performance, combined with its attractive valuation metrics, reinforces the conclusion that Sicagen India is undervalued relative to its peers and the broader market.

What is the technical trend for Sicagen India?

As of May 12, 2025, Sicagen India shows a mildly bearish trend overall, influenced by daily moving averages and mixed signals from MACD and Bollinger Bands, despite some mildly bullish indicators on the weekly chart.

As of 12 May 2025, the technical trend for Sicagen India has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD is mildly bearish. The Bollinger Bands show a bullish signal on the weekly chart but are mildly bearish on the monthly. The daily moving averages are mildly bearish, suggesting short-term weakness. The KST is mildly bullish on the weekly but mildly bearish on the monthly, and Dow Theory supports a mildly bullish outlook on both time frames. Overall, the current technical stance is mildly bearish, driven primarily by the daily moving averages and the mixed signals from the MACD and Bollinger Bands.

Who are the top shareholders of the Sicagen India?

The top shareholders of Sicagen India include Ranford Investments Ltd. with 18.7%, followed by individual investors at 28.37%, and Mercantile Ventures Limited at 2.5%. There is also one Foreign Institutional Investor holding 2.42%, while mutual funds have minimal involvement.

The top shareholders of Sicagen India include several key players. The majority shareholders are the promoters, with no pledged promoter holdings reported. The promoter with the highest holding is Ranford Investments Ltd., which holds 18.7% of the shares. <BR><BR>In terms of institutional investors, there is one Foreign Institutional Investor (FII) that holds 2.42% of the company. Additionally, mutual funds have a minimal presence, with three schemes holding 0.0%. <BR><BR>Among public shareholders, Mercantile Ventures Limited is the largest, holding 2.5%. Individual investors collectively hold 28.37% of the shares.

Has Sicagen India declared dividend?

Yes, Sicagen India Ltd has declared a 6% dividend, amounting to 0.6 per share, with an ex-date of September 12, 2024. The company has shown varying total returns over different periods, with significant long-term price growth.

Sicagen India Ltd has declared a 6% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 6%<BR>- Amount per share: 0.6<BR>- Ex-date: 12 Sep 2024<BR><BR>Dividend Yield: 0.88%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, Sicagen India experienced a price return of -25.03% with no dividend return, resulting in a total return of -25.03%.<BR><BR>Over the past year, the company had a price return of 14.83% and a dividend return of 1.02%, leading to a total return of 15.85%.<BR><BR>In the 2-year period, the price return was 44.4% with a dividend return of 2.72%, culminating in a total return of 47.12%.<BR><BR>For the 3-year period, Sicagen India saw a price return of 157.58% and a dividend return of 5.65%, which resulted in a total return of 163.23%.<BR><BR>In the last 4 years, the company achieved a price return of 195.65% along with a dividend return of 9.05%, leading to a total return of 204.7%.<BR><BR>Over the past 5 years, the price return was 352.13% with a dividend return of 18.91%, resulting in a total return of 371.04%.<BR><BR>Overall, Sicagen India has declared a dividend and demonstrated varying total returns across different periods, with significant growth in price returns over the longer term, indicating a positive trend in shareholder value.